awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47126394-19953331-E421-4B42-9366-A1164E1742D1
Q47126394-19953331-E421-4B42-9366-A1164E1742D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47126394-19953331-E421-4B42-9366-A1164E1742D1
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
P2860
Q47126394-19953331-E421-4B42-9366-A1164E1742D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47126394-19953331-E421-4B42-9366-A1164E1742D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d9648a6f0cdd8c1b491b8ea77699d0ac72fdc0d
P2860
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer